#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dilated cardiomyopathy Malignant fibrous histiocytoma Retinitis pigmentosa Hereditary hypophosphataemic rickets Spina bifida B-cell lymphoma refractory Juvenile chronic myelomonocytic leukaemia Liposarcoma metastatic Kawasaki's disease Haemophilia B without inhibitors Oesophageal atresia Myotonia Niemann-Pick disease Oesophageal squamous cell carcinoma stage II Ornithine transcarbamoylase deficiency More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Treatment Hepatic angiosarcoma – Life with Disease Osteosarcoma metastatic – Basic Information Tuberous sclerosis complex – Trials in Disease Von Willebrand’s disease – Treatment Idiopathic pulmonary fibrosis – Diagnostics Cystic fibrosis lung Hyperoxaluria – Life with Disease Rett syndrome – Diagnostics Hereditary angioedema – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tumor Necrosis Factor-Alpha Selpercatinib Amy109 Darolutamide Etripamil Idecabtagene Vicleucel Potassium Chloride Lazertinib Quinine Dihydrochloride AVTX-009 Prasugrel Hydrobromide Stx-241 Relacorilant 89ZR-CED88004S Ticagrelor Ngm707 Cagrilintide Glycerol Phenylbutyrate Wt1/Il15/Il15Ra Mrna Dc Ibuprofen Lysine More therapies…

    Learn about Your Condition

    Sexual dysfunction Urinary incontinence Peripheral spondyloarthritis Migraine with aura Biliary tract operation Thymic carcinoma Heart transplant Encephalitis autoimmune Major depression Anal cancer recurrent Dermatitis Triple positive breast cancer Metabolic surgery Diabetic foot infection Cardiac sarcoidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier De Versailles

Centre Hospitalier De Versailles

177 Rue De Versailles, Le Chesnay, Le Chesnay-Rocquencourt, 78150, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Glofitamab with Rituximab or Obinutuzumab and Drug Combination for Untreated Richter’s Syndrome Patients

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    • Glofitamab
    France
  • Study on Amiodarone for Critically Ill Patients After Out-of-Hospital Cardiac Arrest with Shockable Rhythm

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amiodarone Hydrochloride
    France
  • Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

    Recruiting

    3 1
    Investigated Drugs:
    • Efruxifermin
    Belgium Denmark France Germany Greece Italy +2
  • Study on Luspatercept and Epoetin Alfa for Patients with Low-Risk Myelodysplastic Syndrome Without Ring Sideroblasts Who Did Not Respond to ESA

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Epoetin Alfa
    • Luspatercept
    France Italy
  • Study on Avoiding Anticoagulation with Apixaban for Patients with Intracerebral Hemorrhage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Apixaban
    France
  • Study on Maintenance Treatment with Pembrolizumab and Pemetrexed for Stage IV Non-Small Cell Lung Cancer Patients After Initial Chemotherapy and Immunotherapy

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    France
  • Study on Blinatumomab, Ponatinib, and Isatuximab for Adults Aged 18-65 with Newly Diagnosed Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Blinatumomab
    • Isatuximab
    • Ponatinib
    Belgium France
  • Study of hydroxychloroquine with low-dose corticosteroids compared to medium-dose corticosteroids in patients with pulmonary sarcoidosis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    • Prednisolone
    • Prednisone
    France
  • Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

    Recruiting

    3 1
    Investigated Diseases:
    • Cardiac failure
    • Obesity
    Bulgaria Czechia Denmark France Germany Greece +4
  • Study on Adjusting Chemotherapy with Carboplatin and Paclitaxel for Patients with Poor Prognostic Ovarian Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Filgrastim
    • Bevacizumab
    • Carboplatin
    France Italy The Netherlands
Previous Page
1 … 4 5 6 7 8 … 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!